What’s the current market cap for Spirax Group stock?

Spirax Group (SPX) has a market cap of £5.2B as of May 29, 2026.

What is the P/E ratio for Spirax Group stock?

The price to earnings (P/E) ratio for Spirax Group (SPX) stock is 31.52 as of May 29, 2026.

Does Spirax Group stock pay dividends?

Yes, the Spirax Group (SPX) stock pays dividends to shareholders. As of May 29, 2026, the dividend rate is £1.7 and the yield is 2.44%. Spirax Group has a payout ratio of 74.97% on a trailing twelve-month basis.

When is the next Spirax Group dividend payment date?

The next Spirax Group (SPX) dividend payment date is unconfirmed.

What is the beta indicator for Spirax Group?

Spirax Group (SPX) has a beta rating of 1.15. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy Spirax Group stock | £SPX Share Price

07:00

09:10

11:15

13:25

15:30

About Spirax Group

Spirax-Sarco Engineering plc, now known as Spirax Group plc, is a UK-based company providing thermal energy management and fluid technology solutions. The company operates globally in multiple sectors including steam thermal solutions, electric thermal solutions, and fluid path technologies. Founded in 1888, Spirax-Sarco Engineering has developed a significant footprint in its field, emphasizing innovation in energy management and sustainability.

Ticker

£SPX

Sector

Industrials

Primary listing

LSE

Employees

10,072

Headquarters

Cheltenham, United Kingdom

Website

www.spiraxgroup.com

Spirax Group Metrics

BasicAdvanced

£5.2bn

31.52

£2.21

1.15

£1.70

2.44%

What the Analysts think about Spirax Group

Analyst ratings (Buy, Hold, Sell) for Spirax Group stock.

Bulls say / Bears say

Spirax achieved 5% organic revenue growth in FY2025, ahead of global industrial production at 2.1%. Adjusted operating profit rose 6% organically, and margin improved by 30 basis points to 20%.

Electric Thermal Solutions delivered 11% organic sales growth, led by better operations and semiconductor sector demand. Watson-Marlow Fluid Technology Solutions saw 6% growth, driven by a Biopharm rebound in H2 2025.

The board proposed raising the full-year dividend by 3% to 170.0 p per share for 2025, citing strong free cash flow and a reduction in net debt/EBITDA leverage to 1.5x, supporting disciplined capital allocation.

Statutory pretax profit dropped 13% to £226.5m in 2025, with operating margin decreasing to 15.6% from 18.3% due to non-recurring restructuring and amortisation expenses.

Unfavorable currency movements in 2025 reduced sales by around 3% and adjusted operating profit by 4%, maintaining margin pressure should sterling strengthen further.

Trading remained above broader industrial production, but IP was still weak at 1.4% in Q1 2026 (1.5% excluding China), with Europe especially soft, which could limit growth in the first half.

Data summarised monthly by Lightyear AI. Last updated on 22 May 2026.

Spirax Group Financial Performance

Revenues and expenses

QuarterlyAnnual

Q3 24

QoQ growth

Revenue

$37bn

-39.75%

Net income

$45bn

107.52%

Profit margin

37.65%

6.78%

Spirax Group Earnings Performance

Company profitability

QuarterlyAnnual

Q4 23

Q1 24

Q2 24

Q3 24

Q4 24

Actual

$3.69

$2.85

$2.45

$2.42

Expected

$3.55

$2.61

$2.05

$2.31

$3.94

Surprise

3.94%

9.20%

19.51%

4.63%

Latest price is delayed by 15 minutes. Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.

Market data provided by London Stock Exchange, through Infront.

Buy £SPX

Capital at risk

Market closed

Upcoming events

No upcoming events

Bulls say / Bears say

Spirax achieved 5% organic revenue growth in FY2025, ahead of global industrial production at 2.1%. Adjusted operating profit rose 6% organically, and margin improved by 30 basis points to 20%.

Statutory pretax profit dropped 13% to £226.5m in 2025, with operating margin decreasing to 15.6% from 18.3% due to non-recurring restructuring and amortisation expenses.

Unfavorable currency movements in 2025 reduced sales by around 3% and adjusted operating profit by 4%, maintaining margin pressure should sterling strengthen further.

Trading remained above broader industrial production, but IP was still weak at 1.4% in Q1 2026 (1.5% excluding China), with Europe especially soft, which could limit growth in the first half.

Data summarised monthly by Lightyear AI. Last updated on 22 May 2026.

About Spirax Group

Ticker

Primary listing

Employees

Spirax Group Metrics

Price and volume

Financial strength

Profitability

Management effectiveness

Valuation

Growth

What the Analysts think about Spirax Group

Analyst Ratings

Bulls say / Bears say

Spirax Group Financial Performance

Income Statement

Spirax Group Earnings Performance

Earnings per share (EPS)

Buy £SPX

Upcoming events

No upcoming events

Lightyear

Legal

Work with us

Bulls say / Bears say

Spirax Group/£SPX

About Spirax Group

Ticker

Primary listing

Employees

Spirax Group Metrics

Price and volume

Financial strength

Profitability

Management effectiveness

Valuation

Growth

What the Analysts think about Spirax Group

Analyst Ratings

Bulls say / Bears say

Spirax Group Financial Performance

Income Statement

Spirax Group Earnings Performance

Earnings per share (EPS)

Buy £SPX

Upcoming events

No upcoming events

What’s the current market cap for Spirax Group stock?

What is the P/E ratio for Spirax Group stock?

Does Spirax Group stock pay dividends?

When is the next Spirax Group dividend payment date?

What is the beta indicator for Spirax Group?

Bulls say / Bears say